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Current Opinion in
NeurobiologyPTEN-induced kinase 1 (PINK1) and Parkin: Unlocking
a mitochondrial quality control pathway linked to
Parkinson’s disease
Shalini Agarwal1 and Miratul M. K. Muqit1,2Abstract
Dissection of the function of two Parkinson’s disease-linked
genes encoding the protein kinase, PTEN-induced kinase 1
(PINK1) and ubiquitin E3 ligase, Parkin, has illuminated a
highly conserved mitochondrial quality control pathway found
in nearly every cell type including neurons. Mitochondrial
damage-induced activation of PINK1 stimulates
phosphorylation-dependent activation of Parkin and ubiquitin-
dependent elimination of mitochondria by autophagy (mitoph-
agy). Structural, cell biological and neuronal studies are
unravelling the key steps of PINK1/Parkin-dependent mitoph-
agy and uncovering new insights into how the pathway is
regulated. The emerging role for aberrant immune activation as
a driver of dopaminergic neuron degeneration after loss of
PINK1 and Parkin poses new exciting questions on cell-
autonomous and noncell-autonomous mechanisms of PINK1/
Parkin signalling in vivo.
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links to Parkinson’s disease pathogenesis
Parkinson’s disease (PD) has emerged as the fastest-
growing neurodegenerative disorder worldwide charac-
terised by motor symptoms including tremor and
nonmotor symptoms such as cognitive decline [1,2].www.sciencedirect.comPathological studies of postmortem brain tissue
of patients with PD reveal characteristic loss of dopamine
neurons from the substantia nigra pars compacta region in
the brain and accumulation of a-synuclein positive in-
clusions known as Lewy bodies (LBs) [1]. The role of
mitochondrial dysfunction in PD emerged in the 1980s
with the discovery that mitochondrial toxins, such as 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine, recapitu-
late selective nigral degeneration in humans and animals,
and biochemical analysis of PD brain tissue revealed
defects in mitochondrial respiratory chain enzyme com-
plexes [3]. However, the molecular basis of how mito-
chondrial dysfunction leads to PD remained unknown till
pioneering genetic studies that identified approximately
20 genes and loci (designated PARK) linked to mono-
genic forms of PD [4]. Autosomal recessive-inherited
causal mutations in human PTEN-induced kinase 1
(PINK1) and the RING-IBR-RING E3-ubiquitin (Ub)
ligase Parkin (encoded by PARK6 and PARK2 genes,
respectively) were discovered in patients with early-
onset PD [5,6] (Figure 1). Molecular analysis demon-
strated these proteins function together in a common
mitochondrial signalling pathway in which PINK1 phos-
phorylates Ub (phospho-ubiquitin) and Parkin. This
triggers Parkin activation and Ubiquitin-dependent
removal of damaged mitochondria by autophagy
(mitophagy). This model correlates very well with clin-
ical data in which PINK1 and patients with Parkin PD
have indistinguishable phenotypes with early-onset and
sustained responsiveness to L-Dopa therapy and similar
pathology with general paucity of LBs [7].
Parallel studies of postmortem brain tissue have
demonstrated elevated levels of phospho-ubiquitin in
aged and sporadic PD cases compared with controls
[8,9]. It has also been reported that Parkin undergoes
oxidative modifications that render it more insoluble
and that it can sequestrate in LBs, leading to reduced
availability of soluble Parkin for native functions
including as a redox molecule [10,11]. A specific role for
PINK1 and Parkin in a-synuclein-driven PD is also
suggested from preclinical models in which a-synuclein-
induced mitochondrial pathologies and dopamine
neurodegeneration are significantly worsened in either
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112 Neurobiology of DiseaseStructural view of PTEN-induced kinase 1 and Parkin
and impact of Parkinson’s disease-causing mutations
Human PINK1 encodes a 581 amino acid (AA) serine
(Ser)/threonine (Thr) protein kinase containing an N-
terminal mitochondrial targeting sequence, a catalytic
kinase domain with three insertions and a C-terminal
hydrophobic extension (Figure 1). Most PD-causing
mutations lie within the kinase domain highlighting
the importance of this region in its protective role
against PD (Figure 1). Structural and biochemical
analysis of constitutively active insect orthologues of
PINK1 namely, Tribolium castaneum [Protein Data Bank
(PDB): 5OAT] and Pediculus humanus corporis in complex
with Ub via a nanobody [PDB: 6EQI] has identified aCurrent Opinion in Neurobiology 2022, 72:111–119critical role of autophosphorylation of a highly conserved
Ser residue (Tribolium castaneum PINK1 (TcPINK1),
Ser205; Pediculus humanus corporis (PhcPINK1)
Ser202) within the N-lobe for activation and Ub sub-
strate recognition [14,15]. Structural analysis also
revealed a previously unidentified role for the third loop
insertion (INS3) in Ub substrate recognition and cata-
lytic activity [14,15]. Mutagenesis studies of human
PINK1 in cells have confirmed conservation of these
mechanisms; however, unequivocal detection of PINK1
autophosphorylation at Ser228 (equivalent to the insect
Ser205/202) is outstanding [14,16,17]. The structures
have provided major insights into the pathogenic
mechanisms of some of the key mutations. Mutationswww.sciencedirect.com
Figure 1
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Domain organisation of human PINK1 and Parkin. Schematic representations of the mitochondrial kinase PINK1 and the RBR-E3 ubiquitin-protein ligase
Parkin. Individual domains are colour coded and labelled: MTS, mitochondrial targeting sequence; TM, transmembrane domain; NT, N-terminal, regu-
latory domain; INS, insertion; CTE, C-terminal extension; UBL, ubiquitin-like domain; ACT, activating element; RING, really interesting new gene domain,
IBR, in-between-RING domain; REP, repressor element; fs, frameshift mutation. PINK1, PTEN-induced kinase 1; RBR-E3, RING-IBR-RING-E3 Selected
PINK1 and Parkin human disease mutations, the phosphosites and regulatory residues referred in the text are highlighted in the domain structure as
black, red and green, respectively.
Mitochondrial quality control pathway linked to Parkinson’s disease Agarwal and Muqit 113within the ATP-binding pocket (Ala217Asp, Glu240Lys,
Ala244Gly and Leu369Pro) and within the activation
loop (Gly386Ala, Pro416Arg/Leu and Glu417Gly) both
resulted in catalytically inactive PINK1, and mutation
within Gly309Asp that lies in INS3 prevented Ub
recognition with the remainder of PD mutations being
likely to affect the structural integrity of PINK1
(Figure 1) [14,15]. The current insect structures do not
provide insights into the role of the N-terminus of
PINK1 as well as the mechanism by which PINK1 un-
dergoes dimerisation on activation in cells [18], and
understanding these in the structural context of
mammalian PINK1 will be essential.
Parkin encodes a 465 AA Ub E3 ligase containing an N-
terminal Ub-like (Ubl) domain, RING0, RING1, in-
between-RING (IBR), repressor element and RING2
domains. The three RING and IBR domains each co-
ordinate two zinc ions that are essential for protein
folding. A previously uncharacterised conserved linker
region between the Ubl domain and RING0 termed the
activating element (ACT) (AA residues 101e109) has
also been identified [19], and it has recently been re-
ported that phosphorylation of a conserved Ser 108
residue within the ACTelement by Unc-51 autophagy-
activating kinase 1(ULK1) is required for optimal acti-
vation of Parkin in cells, and this presages PINK1-
mediated phosphorylation of Ser65 within the Ublwww.sciencedirect.comdomain (Figure 1) [20]. Other key functional residues of
Parkin include the catalytic cysteine residue (Cys431)
that lies within the RING2 domain [21,22] and His302
on the RING1 domain that has been identified as an
essential phospho-ubiquitin-binding residue [23e25].
Numerous PD-causing mutations have been identified
including rearrangements that drastically destabilise the
protein and missense mutations across the whole pro-
tein that disrupt critical regulatory AA residues, for
example [Cys431Phe] within RING2 that disrupts the
Ub thioester formation required for Ub transfer to
substrates [21,22], Ser65Asn that prevents phosphory-
lation and activation by PINK1 [26], and
Lys161Asn Lys211Asn mutants that disrupt the phos-
phoacceptor pocket on RING0 for pSer65-Ubl thereby
preventing release of RING2 and Parkin activation and
associated with defective recruitment to damaged
mitochondria in cells [19,27].
Upstream mechanism of stress-evoked mitophagy:
regulation of Parkin activation by PTEN-induced
kinase 1
Under basal conditions, PINK1 is present at low levels
owing to proteolytic turnover, and Parkin is localised in
the cytosol where it exists in an autoinhibited confor-
mation mediated by three autoinhibitory interfaces
[28]. On mitochondrial depolarisation, induced by
uncoupling agents (e.g. carbonyl cyanide m-Current Opinion in Neurobiology 2022, 72:111–119
Figure 2
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Model for PINK1-Parkin activation and mitophagy. PINK1-Parkin directed mitochondrial clearance is well-established, and recent findings have further
added new paradigms to the molecular regulation of mammalian mitophagy. Mitochondrial damage induced by the depolarising agent such as CCCP/
oligomycin-antimycin causes rapid increase in AMP and mitochondrial reactive oxygen species (mtROS) which is sensed by AMPK within minutes to
phosphorylate and activate the kinase ULK1. Activated ULK1 phosphorylates Parkin in its ACT domain marking the first step in mitophagy cascade.
Meanwhile, PINK1 also gets autophosphorylated and accumulates on the outer mitochondrial membrane (OMM) where it phosphorylates Parkin to finally
activate its E3 ligase activity. Activated Parkin then triggers cycles of ubiquitylation on the OMM, resulting in recruitment of autophagy receptors,
autophagosome formation eventually culminating in elimination of damaged mitochondria through mitophagy. AMPK, AMP-activated protein kinase;
CCCP, carbonyl cyanide m-chrolophenyl hydrazone; PINK1, PTEN-induced kinase 1; ULK1, Unc-51 autophagy activating kinase 1.
114 Neurobiology of Diseasechrolophenyl hydrazone/oligomycin-antimycin), PINK1
is stabilised at the outer mitochondrial membrane
(OMM) in association with components of the translo-
case of the outer membrane complex where it undergoes
dimerisation, autophosphorylation and activation
(Figure 2) [16,18,29,30]. PINK1 initially phosphorylates
Ub attached to OMM proteins specifically at residue
Ser65 (phospho-ubiquitin) leading to recruitment of
Parkin to the OMMwhereon it binds phospho-ubiquitin
and undergoes a conformational change that stimulates
PINK1 to phosphorylate its Ubl domain at residue Ser65
equivalent to the Ub site (Figure 2) [23e25]. Structural
analysis of the regulation of Parkin by PINK1 has
revealed the central role of phosphorylation in convert-
ing Parkin from an inactive autoinhibited confirmation
[31e34] to a fully active enzyme capable of ubiq-
uitylating myriad substrates at the OMM [19,35].
Phospho-ubiquitin binding to Parkin leads to minor
movement of the H3 helix (within the RING0 domain),
but this is sufficient to dissociate the Ubl domain fromCurrent Opinion in Neurobiology 2022, 72:111–119the IBR domain and opens up a new pocket at the H3-
IBR interface and the RING1 interface for binding of
donor Ub and E2; phosphorylation of the Ubl domain
leads to its major displacement and binding to a charged
pocket within the RING0 domain that disrupts the
RING0-RING2 interface to release RING2 availing the
catalytic Cys, Cys431 for transthiolation by the charged
E2-Ub [19,35].
A recent study has found that mitochondrial depolar-
isation-dependent PINK1-Parkin activation also con-
verges with the adenosine 5-monophosphate (AMP)-
activated protein kinase (AMPK) signalling pathway
[20]. AMPK is rapidly activated after any stress that
triggers mitochondrial damage depleting ATP levels and
concomitantly elevating AMP. In response to mito-
chondrial depolarisation, AMPK is fully activated in the
cytosol within 2 min and directly phosphorylates its
substrates Raptor, acetyl-CoA carboxylase (ACC) and
ULK1 [20]. Strikingly, Parkin is phosphorylated bywww.sciencedirect.com
Mitochondrial quality control pathway linked to Parkinson’s disease Agarwal and Muqit 115ULK1 at Ser108 within the ACT element at this early
time point of minutes followed by rapid recruitment of
ULK1 and AMPK to the mitochondria [20]. This pre-
sages PINK1-dependent phosphorylation of Parkin and
Ub whose temporal dynamics may be slowed by the
requirement of PINK1 stabilisation on the OMM
(Figure 2) [20].
Downstream mechanism of stress-evoked
mitophagy: ubiquitin mediated recruitment of
autophagy receptors and mitoautophagosome
formation
Studies in HeLa cells and neurons have indicated that
accumulation of Ub and/or phospho-ubiquitin on
damaged mitochondria stimulates recruitment of auto-
phagy adaptor receptors including optineurin (OPTN),
NDP52/(coiledecoiled domain-containing protein 2)
and Tax-1-binding protein (TAX1BP1) [36e38].
CRISPR/Cas9 knockout experiments suggest that
NDP52 and OPTN are essential for PINK1/Parkin-
dependent mitophagy, and TAXBP1 has a lesser effect
[37,38], but how these receptors are recruited to
damaged mitochondria remains to be fully elucidated.
Previous mass spectrometry analysis of ubiquitylation in
HeLa cells over-expressing Parkin revealed upregulation
of diverse Ub chain types including K6, K11, K48 and
K63 [39e42] of which K6 chains were quantified as the
predominant chain type [42]. In contrast, in physiolog-
ically more relevant cell types that express endogenous
levels of Parkin including human embryonic stem cell
(ESC)-derived dopamine neurons, human iNeurons and
mouse primary cortical neurons, K63 chains were
exclusively or predominantly upregulated after mito-
chondrial depolarisation [39,43]. On PINK1/Parkin
activation, OPTN1 recruitment to mitochondria is
associated with activation of TANK-binding kinase 1
(TBK1) that phosphorylates OPTN1 to increase its af-
finity for Ub chain binding that promotes further
OPTN1 recruitment to damaged mitochondria and
TBK1 activation and also enhances binding to micro-
tubule-associated protein 1A/1B-light chain 3A (LC3 A)
to drive mitophagy [37,44]. TBK1 also phosphorylates
ras-associated binding (Rab)7 at Ser72 that has been
reported to be critical for mitophagy via recruitment of
autophagy-related protein 9A-positive vesicles to
damaged mitochondria [37]. ULK1, double FYVE-
containing protein 1 and WD repeat phosphoinositide-
interacting protein 1 stimulate LC3 recruitment and
subsequent mitoautophagosome formation. Further-
more, it has been reported that NDP52 and TBK1
jointly recruit a second wave of the ULK1 complex to
ubiquitylated cargo at the mitochondria, leading to
ULK1 kinase activation, which occurs independently of
energy-sensing pathways (AMPK and mechanistic
target of rapamycin kinase) and Parkin Ser108 phos-
phorylation [45]. Consistent with this, reconstitutionwww.sciencedirect.comstudies have recently demonstrated that cargo-loaded
NDP52, OPTN and TAX1BP1 stimulate LC3 lipida-
tion in the presence of purified autophagy initiation
complexes expressed at appropriate physiological (nM)
concentrations and furthermore that NDP52 and
TAX1BP1 but not OPTN promote ULK1 complex
recruitment to the membrane [46]. Recently, it has
been proposed that Parkin generates short chains
including branched Ub species in both HeLa cells and
human iNeurons [42,47], and in future studies, it will be
interesting to directly assess the role of specific Ub
chain linkages (e.g. K6 vs K63) as well as chain length in
a reconstitution system.PTEN-induced kinase 1/parkin mitophagic signalling
in neurons
Initial mass spectrometry studies in HeLa cells over-
expressing Parkin not also identified myriad substrates,
mainly localised to the mitochondria, but also included
substrates in the cytosol and other cell compartments
[41]. Recent comparative analysis of Lys-e-Gly-Gly (di-
GLY) proteomic data sets of human iNeurons and pri-
mary mouse cortical neurons in which PINK1/Parkin is
expressed under endogenous levels has revealed a
common set of 49 diGLY Ub sites spanning 22 OMM
proteins [43,47]. This represents a defined Parkin-
dependent ubiquitylation signature of damaged mito-
chondria, and in future studies, it will be interesting to
assess this in Dopaminergic (DAergic) neurons as well
as non-central nervous system (CNS) cell types. In
human iNeurons, it has been demonstrated that
increased Parkin-mediated ubiquitylation of OMM
substrates is associated with mitochondrial stress-
evoked mitophagy that is absolutely PINK1 depen-
dent. This is distinct from basal levels of mitophagy
detected in iNeurons that are independent of PINK1
[47]. Basal mitophagy is also independent of PINK1 and
Parkin in knockout models in vivo [26,48], although
these mice lines are reported to exhibit no robust
phenotype or only mild phenotypes without striatonigral
degeneration, for example, Parkin knockout mice
[49,50]. Analysis of Parkin-dependent mitophagy in
mouse hippocampal neurons suggests a high degree of
spatiotemporal regulation with Parkin/OPTN and TBK1
recruitment occurring in the cell body and rarely in the
axon, suggesting alternate pathways may regulate
mitophagy in axons [36]. Complementary in vivo analysis
of Parkin knockout mice crossed with the ‘mutator’
mouse model, that induces mitochondrial stress owing
to mutation in Polg, led to age-dependent DA neuron
loss and levodopa-responsive motor dysfunction [51].
This confirms that endogenous Parkin has a critical role
in protecting nigral neurons against mitochondrial
dysfunction/accumulation of mitochondrial DNA
(mtDNA) mutations in vivo consistent with its functions
on neurons in vitro.Current Opinion in Neurobiology 2022, 72:111–119
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mechanisms of immunology linked to
neurodegeneration
Innate immune signalling
Akin to bacterial components, escape of mtDNA to the
cytosol can trigger innate immune signalling pathways
that trigger toll-like receptor 9-mediated type I inter-
feron (IFN) or nuclear factor kappa-light-chain-
enhancer of activated B cell inflammatory responses
[52] or activation of the NLR family pyrin domain-
containing 3 inflammasomes [53]. In a similar manner,
the combination of mitochondrial stress and failure to
remove damaged mitochondria by loss of PINK1/Parkin
has also been shown to stimulate innate immune re-
sponses via activation of cyclic GMP-AMP synthase/Figure 3
Emerging PINK1 immune signalling pathways. Our knowledge of the involvem
new observations suggest their significant role in innate immunity and inflamm
Parkin-dependent generation of MDVs enabling the shuttling of damaged mito
presentation (MitAP) of the mitochondrial antigens on Major Histocompatibility
cell activation. In addition to MitAP, PINK1-Parkin has also been shown to mi
mtDNA released into the cytosol on mitochondrial damage and permeabilisatio
and Damage associated molecular patterns (DAMPs) also trigger the NLRP3
cytokine signalling and activation of glial cells. The activation of the PINK1 si
vesicular trafficking and autolysosomal clearance. Several Rab GTPases such
activation at the Ser111 residue via yet unidentified phosphorylation events. A
cGAS, cyclic GMP-AMP synthase; STING, stimulation of interferon genes; MD
reticulum; PM, plasma membrane; CCV, clathrin-coated vesicle. PINK1, PTE
Current Opinion in Neurobiology 2022, 72:111–119stimulator of interferon gene (STING)-mediated type
1 IFN response (Figure 3) [54]. PINK1 or Parkin
knockout mice crossed with mutator mice or exposed to
exhaustive exercise exhibited high levels of cytokines
including interleukin (IL)-6, IL-12, and IFN-beta in
the serum [54]. Strikingly genetic inactivation of
STING blocked exercise-induced cytokine production
and prevented the development of neurodegeneration
in the double-mutant Parkin/mutator mice [54]. This
contrasts with findings in Drosophila in which loss of
STING does not affect behavioural and mitochondrial
phenotypes of PINK1 and Parkin mutant flies [55].
Clinically, patients with Parkin are also found to have
higher serum levels of IL-6 than those of controls [54],
and this has been recently confirmed in independentCurrent Opinion in Neurobiology
ent of PINK1 and Parkin in cellular mitophagy has expanded, and several
ation. Independent of classical mitophagy, a physiological role for PINK1-
chondrial proteins to lysosomes has been reported. Mitochondrial antigen
Complex 1 (MHC1) molecules then drives mitochondria-specific CD8+ T-
tigate proinflammatory signalling pathways causing neuroinflammation.
n triggers cGAS-STING-mediated type I interferon response. The mtDNA
inflammasome pathway leading to caspase-1-dependent proinflammatory
gnalling pathway also has been implicated in Rab GTPases-mediated
as Rab8A, Rab8B and Rab13 are known to get phosphorylated on PINK1
bbreviations: mtA, mitochondrial antigen; mtDNA, mitochondrial DNA;
Vs, mitochondria-derived vesicles; TCR, T-cell receptor; ER, endoplasmic
N-induced kinase 1; Rab, ras-associated binding; Ser111, serine 111.
www.sciencedirect.com
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and Parkin mutations [56]. Furthermore, a recent study
has also found that cytosolic mtDNA is increased in
idiopathic PD brain tissues and in zebrafish models of
mutant PINK1, glucocerebrosidase (GBA1) and
ATP13A2 that are sensed by IFI16 to induce type I
interferon responses [57]. These exciting findings raise
many questions regarding whether age-dependent
mutated or oxidised mtDNA (that might accrue in
PD) are differentially sensed to selective immune ma-
chinery and which cell types do these mechanisms
occur to trigger nigral DAergic neuronal loss in PD and
whether this is cell-autonomous or not.
Adaptive immune signalling
Parallel studies in immortalised cell lines indicate that
activation of PINK1/Parkin can induce autophagy-
independent mitochondrial turnover including
mitochondria-derived vesicles (MDVs) that shuttle
cargoes to lysosomes for degradation [58,59]. Mecha-
nistically, PINK1/Parkin-dependent MDVs appear to be
distinct to that of mitophagy, occurring independent of
Dynamin-related protein 1 (Drp1) and requiring the
Soluble NSF attachment proteins (SNAP) REceptor
(SNARE) syntaxin-17 to mediate MDV endolysosome
fusion [59,60]. Whilst MDV formation is dependent on
Parkin catalytic activity, how Ub chains or specific sub-
strates are involved in this process remains unknown.
Physiologically, MDVs have been linked to mitochon-
drial antigen presentation (MitAP), and loss of PINK1
and/or Parkin drives MDV formation in immune cells
which facilitates MitAP (Figure 3) [61]. Furthermore,
exposure of PINK1-knockout mice to intestinal infec-
tion by Gram-negative bacteria led to a MitAP response
and the induction of cytotoxic mitochondrial CD8þ T
cells in the periphery, triggering dopaminergic patho-
logical deficits in the brain and L-Dopa-responsive motor
deficits [62]. This raises exciting follow-up studies on
the cell specificity of these mechanisms in vivo and
which specific substrates of PINK1 and Parkin control
MDVs and MitAP. Generation of MDVs and MitAP is
dependent on SNX9 and Rab9, and SNX9 levels have
been observed to be regulated by Parkin, although it isBox 1. Outstanding questions in the field:
1. What upstream mitochondrial stress pathways activate PINK1-Parkin
2. Are triggers of mitochondrial damage in idiopathic PD distinct from P
3. What is the structure and activation mechanisms of full-length mamm
4. What is the structural mechanism by which Parkin attaches Ub to su
5. What are the physiological Ub signals that signal phagophore format
6. What is cell specificity of the STING pathway, and is dopamine cell lo
7. What is the cell specificity of MitAP mechanisms of neurodegeneratio
8. What Ub E3 ligases or kinases compensate for loss of PINK1/Parkin
9. Are there additional DUBs and phosphatases that negatively regulat
10. What is the physiological role of PINK1-mediated Rab phosphorylatio
www.sciencedirect.comunknown whether SNX9 is ubiquitylated by Parkin
[61]. PINK1 has also been reported to induce phos-
phorylation of a highly conserved Ser111 residue on a
subset of Rab GTPases, including Rab8A, Rab8B and
Rab13. The regulation of Rabs by PINK1 appears to be
indirect, and it remains unknown whether phosphory-
lation of these proteins influences MDV formation and
trafficking [63].
Concluding remarks
PINK1 and Parkin research progress to date has been
exemplar in demonstrating how understanding the
normal function of PD genes is a critical first step to
elucidate the fundamental mechanisms by which mu-
tations lead to DAergic cell loss. This has revealed the
central role mitochondrial homeostasis plays in neuronal
integrity and survival in the ageing brain. The discovery
that loss of PINK1 and Parkin can induce DAergic
dysfunction via immune hyperactivation opens up new
avenues for investigation on cell-autonomous and
noncell-autonomous mechanisms of PINK1/Parkin
signalling in vivo. Activated microglia and astrocytes play
an important role in neuroinflammation in the CNS, and
in future work, it will be critical to determine the mo-
lecular role of PINK1 and Parkin in these cell types.
Therapeutically, activation of PINK1 and Parkin is a
potential strategy to prevent neurodegeneration; how-
ever, screening and identification of small molecule ac-
tivators remain challenging in drug discovery research.
Defining the negative regulators of PINK1/Parkin
signalling has revealed mitochondrial localised Ub-spe-
cific protease 30 as a candidate deubiquitinase [64]. Ub-
specific protease 30 promotes efficient import of mito-
chondrial proteins, and its inhibition can enhance
PINK1-catalysed phospho-ubiquitin accumulation after
mitochondrial damage [47,65]. Another major question
is defining parallel mitophagic pathways that may
compensate for loss of PINK1 and Parkin. In neurons,
multiple proteins are ubiquitylated in response to
mitochondrial damage independent of PINK1 and
Parkin; however, the ubiquitin E3 ligases that mediate
this are unknown [43,47]. Mitochondrial ubiquitin
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118 Neurobiology of Diseaseligase activator of NF- kB (MULAN) and mitochondrial
associated protein ligase (MAPL)) functions with Parkin
to regulate degradation of paternal mitochondria from
sperm, but the mechanism by which MUL1 induces
mitophagy is unknown [66]. Furthermore, mitochon-
drial fusion factors mitofusin1/2 have been reported to
be ubiquitylated by MUL1, Membrane-associated
RING finger protein 5 (MARCH5), Mahogunin RING
finger protein 1 (MGRN1) and HECT, UBA and WWE
domain-containing protein 1 (HUWE1) as well as Parkin
under distinct cellular stress, but no studies have sys-
tematically addressed their interdependence under
mitophagic stress conditions [67]. Looking at the
future, these and many other questions (Box 1) remain
to be addressed to define the key mitochondrial mech-
anisms relevant to PD pathogenesis.Funding
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